CIK 0001515673 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 673.0 M | 363.3 M |
| Net income (USD) | -575.0 M | -707.4 M |
| Diluted EPS (USD/shares) | -5.83 | -10.12 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-19 | 4 | 4 | 2026-10-15 |
| 2026-10-19 | 8-K | 8-K items 8.01 | 2026-10-19 |
| 2026-10-14 | 8-K | 8-K items 1.01 | 2026-10-08 |
| 2026-10-07 | 8-K | 8-K items 1.01 | 2026-10-06 |
| 2026-09-17 | 8-K | 8-K items 8.01 | 2026-09-17 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 144 | 144 | |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-09-02 | 8-K | 8-K items 8.01 | 2026-09-02 |
| 2026-08-19 | 8-K | 8-K items 8.01 | 2026-08-19 |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-13 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-11 | 8-K | 8-K items 8.01 | 2026-08-07 |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-08-04 | 4 | 4 | 2026-08-03 |
| 2026-08-04 | 4 | 4 | 2026-08-03 |
| 2026-08-03 | 144 | 144 | |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-30 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-06 | 4 | 4 | 2026-07-01 |
| 2026-07-01 | 144 | 144 |
Forms on file (last 1,000): 4 514, 8-K 191, SC 13G/A 57, 144 39, 10-Q 34, 3 16, 424B5 16, S-8 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RARE (0.002 USD), /gw/filings/filings?ticker=RARE&form=8-K, /gw/filings/facts?ticker=RARE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange